Table 1.
Original cardiac diagnosis, n (%) | |
---|---|
Tetralogy of Fallot | 65 (48) |
Pulmonary atresia | 40 |
Pulmonary stenosis | 19 |
Absent pulmonary valve | 5 |
Atrioventricular canal | 1 |
Aortic valve disease after Ross operation | 28 (21) |
Transposition of the great arteries | 15 (11) |
Truncus arteriosus | 14 (10) |
Double-outlet right ventricle | 8 (6) |
Valvar pulmonary stenosis | 3 (2) |
Other | 2 (1) |
NYHA functional class, n (%) | |
I | 22 (16) |
II | 91 (67) |
III | 22 (16) |
IV | 1 (1) |
Type of conduit or pulmonary valve, n (%) | |
Homograft | 103 (76) |
Bioprosthetic valve or conduit* | 26 (19) |
Synthetic | 7 (5) |
Previously placed conduit stent, n (%) | |
No | 100 (74) |
Single stent | 23 (17) |
Multiple stents | 12 (9) |
No report | 1 (1) |
Median (range) conduit/valve diameter at the time of surgical implantation, mm | 21 (16–28) |
Number of prior surgical conduits | |
Median (range), n | 1 (1–5) |
>1, n (%) | 65 (48) |
Data reflect the number of patients and the percentage of the catheterized cohort (n=136) or the median and range as appropriate.
Includes bioprosthetic valves, conduits with integrated bioprosthetic valves, and nonhomograft biological conduits (eg, Contegra).